SHED-CM Ameliorates Neuropathic Pain
Liu, Yao Tokushima University
Kano, Fumiya Tokushima University Tokushima University Educator and Researcher Directory
Hashimoto, Noboru Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Xia, Linze Tokushima University
Zhou, Qiao Nantong University
Feng, Xingmei Nantong University
Hibi, Hideharu Nagoya University
Miyazaki, Aya Tokushima University Tokushima University Educator and Researcher Directory
Matsuka, Yoshizo Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Zhang, Zhijun Nantong University
Tanaka, Eiji Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Yamamoto, Akihito Tokushima University Tokushima University Educator and Researcher Directory
dental pulp stem cells
In neuropathic pain (NP), injury or diseases of the somatosensory system often result in highly debilitating chronic pain. Currently, there is no effective drug for the complete and definitive treatment of NP. We investigated the therapeutic potential of conditioned medium (CM) derived from stem cells from human exfoliated deciduous teeth (SHED-CM) against NP using a mouse partial sciatic nerve ligation (PSL) model. Abnormal pain sensation, such as tactile allodynia and hyperalgesia, can be caused by PSL. In the behavioral test, intravenous administration of SHED-CM greatly improved the PSL-induced hypersensitivity. We found that treatment with SHED-CM resulted in the recruitment of M2 macrophages in the injured sciatic nerve and ipsilateral L4/L5 dorsal root ganglion and suppressed microglial activation in the spinal cord. Notably, specific depletion of the anti-inflammatory M2 macrophages by mannosylated-Clodrosome markedly reduced the antinociceptive effect of SHED-CM. Intravenous administration of CM from M2 induced by SHED-CM (M2-CM) ameliorated the PSL-induced hypersensitivity. We found that M2-CM directly suppressed the expression of nociceptive receptors as well as proinflammatory mediators in Schwann cells. Taken together, our data suggest that SHED-CM ameliorates NP through the induction of the analgesic anti-inflammatory M2 macrophages. Thus, SHED-CM may be a novel therapeutic candidate for NP.
Frontiers in Pharmacology
Frontiers Media S.A.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
|DOI (Published Version)
|URL ( Publisher's Version )
fphar_13_745020.pdf 5.32 MB